Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

COUCH Medcomms

Woman on mobile phone

How femtech is changing the future of women’s health

The femtech industry has the potential to be the next stage of evolution in the open access movement. Taking on the role of a public library, which allows a wider...

Thrive Agency

- PMLiVE

Not another thought leadership article… sorting the wheat from the chaff

By Rob Barlow

Revolutionising the Digital Content Delivery Model

Pharmaceutical industry processes don’t have to make the delivery of marketing campaigns slow and unmanageable, and thus ineffective. Changing working practices and really, truly thinking differently about how to deliver...

M3 (EU)

- PMLiVE

Fishawack Health welcomes expert-led dermatology initiative FIDE to its group

Fishawack Health welcomes FIDE, an independent organization providing its clients with insight from clinical key opinion leaders in inflammatory dermatology

Avalere Health

- PMLiVE

Moderna clashes with US government over COVID-19 vaccine

A year-long wrangle with the US government over who invented a core component of the Moderna COVID-19 vaccine could have far-reaching implications

- PMLiVE

Pfizer snaps up Biohaven’s migraine drug for $1.24bn

Pfizer will sell the migraine drug outside the US and will also gain the rights to a second drug

Graphic showing person with megaphone and two speech bubbles

Opening up about patient engagement

Read the third blog of the series looking at key barriers to effective patient engagement in pharma

Cuttsy + Cuttsy

regeneron headquarters

Regeneron’s antibody cocktail REGEN-COV offers sustained protection against COVID-19

The drug is shown to give sustained protection against COVID-19, cutting the risk of infection by more than 80% for up to eight months

- PMLiVE

BMS’ Opdivo improves survival in early-stage lung cancer

Pre-surgical Opdivo improves survival in non-small cell lung cancer patients, reinforcing its efficacy in early-stage cancers

- PMLiVE

Rethinking immunodermatology: Patient and market insights from leading KOLs and life science leaders

In our new publication, we speak to key opinion leaders and industry experts to uncover novel strategies for commercializing immunodermatology therapies in a crowded market landscape.

Avalere Health

- PMLiVE

Delivering outcomes-led solutions with connected capabilities

Founded in 2007, Lucid Group has grown from a small UK-based medical education agency to a global healthcare consultancy and employs over 400 people with several offices in the UK...

Lucid Group Communications Limited

- PMLiVE

Pfizer’s oral antiviral Paxlovid significantly cuts risk of severe COVID-19

Pfizer has halted its phase 2/3 trial of its new antiviral combo Paxlovid after analysis shows it cuts the risk of hospitalisation or death from COVID-19 by nearly 90%

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links